Lethal experimental cancer drug from Hanmi, Boehringer killed three patients — report
Korean health officials have tied the deaths of three patients to a cancer drug launched by Hanmi Pharmaceuticals and partnered with Boehringer Ingelheim, according to a followup story in The Korea Herald.
Citing a report from the country’s Ministry of Food and Drug Safety, which was released by Rep. Kwon Mi-hyuk today, the three were a 75-year-old patient who died in late 2015, a 57-year-old who died in March and a 54-year-old who died in June.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.